ZBIO logo

Zenas BioPharma, Inc. (ZBIO)

Profile

Full Name

Zenas BioPharma, Inc.

Ticker

NASDAQ: ZBIO

Exchange

NASDAQ

Country

United States

IPO

September 13, 2024

Indexes

Not included

Employees

130

Key Details

Price

$20.23(+0.30%)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$5.00M(-90.00% YoY)

Annual EPS

-$11.89(-100.00% YoY)

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
See Full Chart & Historical Data

Analyst ratings

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

May 16, 25 HC Wainwright & Co.
Buy
Mar 20, 25 Wedbush
Outperform
Mar 12, 25 HC Wainwright & Co.
Buy
Mar 12, 25 Guggenheim
Buy
Feb 4, 25 Wolfe Research
Outperform
Dec 16, 24 HC Wainwright & Co.
Buy
Dec 11, 24 Morgan Stanley
Overweight
Dec 3, 24 Guggenheim
Buy

Institutional Ownership

  • What is the ticker symbol for Zenas BioPharma, Inc.?
  • Does Zenas BioPharma, Inc. pay dividends?
  • What sector is Zenas BioPharma, Inc. in?
  • What industry is Zenas BioPharma, Inc. in?
  • What country is Zenas BioPharma, Inc. based in?
  • When did Zenas BioPharma, Inc. go public?
  • Is Zenas BioPharma, Inc. in the S&P 500?
  • Is Zenas BioPharma, Inc. in the NASDAQ 100?
  • Is Zenas BioPharma, Inc. in the Dow Jones?
  • When was Zenas BioPharma, Inc.'s last earnings report?
  • When does Zenas BioPharma, Inc. report earnings?

What is the ticker symbol for Zenas BioPharma, Inc.?

The ticker symbol for Zenas BioPharma, Inc. is NASDAQ:ZBIO

Does Zenas BioPharma, Inc. pay dividends?

No, Zenas BioPharma, Inc. does not pay dividends

What sector is Zenas BioPharma, Inc. in?

Zenas BioPharma, Inc. is in the Healthcare sector

What industry is Zenas BioPharma, Inc. in?

Zenas BioPharma, Inc. is in the Biotechnology industry

What country is Zenas BioPharma, Inc. based in?

Zenas BioPharma, Inc. is headquartered in United States

When did Zenas BioPharma, Inc. go public?

Zenas BioPharma, Inc.'s initial public offering (IPO) was on September 13, 2024

Is Zenas BioPharma, Inc. in the S&P 500?

No, Zenas BioPharma, Inc. is not included in the S&P 500 index

Is Zenas BioPharma, Inc. in the NASDAQ 100?

No, Zenas BioPharma, Inc. is not included in the NASDAQ 100 index

Is Zenas BioPharma, Inc. in the Dow Jones?

No, Zenas BioPharma, Inc. is not included in the Dow Jones index

When was Zenas BioPharma, Inc.'s last earnings report?

Zenas BioPharma, Inc.'s most recent earnings report was on August 12, 2025

When does Zenas BioPharma, Inc. report earnings?

The next expected earnings date for Zenas BioPharma, Inc. is November 11, 2025
On this page